Invention Grant
- Patent Title: Maillard reaction products as inhibitors of aggregatibacter actinomycetemcomitans
-
Application No.: US16819889Application Date: 2020-03-16
-
Publication No.: US11324776B2Publication Date: 2022-05-10
- Inventor: Raniah Abdulmohsen Afif Jaha
- Applicant: National Guard Health Affairs , King Saud bin Abdulaziz University for Health Sciences , King Abdullah International Medical Research Center
- Applicant Address: SA Riyadh; SA Riyadh; SA Riyadh
- Assignee: National Guard Health Affairs,King Saud bin Abdulaziz University for Health Sciences,King Abdullah International Medical Research Center
- Current Assignee: National Guard Health Affairs,King Saud bin Abdulaziz University for Health Sciences,King Abdullah International Medical Research Center
- Current Assignee Address: SA Riyadh; SA Riyadh; SA Riyadh
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61K35/02
- IPC: A61K35/02 ; A61P31/04 ; A61P1/02 ; A61K31/7012
Abstract:
Maillard reaction products produced by heating carbohydrates with one or more amino acids (e.g., lysine), at basic pH and for a selected reaction time at a particular concentration in solution, can exhibit inhibitory activity against Aggregatibacter actinomycetemcomitans.
Public/Granted literature
- US20210283154A1 MAILLARD REACTION PRODUCTS AS INHIBITORS OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS Public/Granted day:2021-09-16
Information query
